Production (Stage)
Kronos Bio, Inc.
KRON
$0.8726
$0.00060.07%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 44.60% | 23.60% | 28.16% | 14.30% | 5.51% |
| Total Depreciation and Amortization | -28.45% | -19.66% | -20.03% | -17.88% | -10.36% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -24.20% | 41.19% | -15.96% | -9.80% | 10.72% |
| Change in Net Operating Assets | -5.64% | -404.51% | -247.61% | -231.31% | -197.48% |
| Cash from Operations | 43.67% | 16.73% | -2.02% | -15.74% | -31.54% |
| Capital Expenditure | 100.54% | 99.41% | 95.57% | 54.92% | -66.17% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 25.88% | 27.43% | 40.78% | 229.88% | 764.09% |
| Cash from Investing | 26.78% | 28.73% | 42.21% | 234.58% | 741.23% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -56.61% | -56.61% | -5.59% | -64.64% | -45.38% |
| Repurchase of Common Stock | -- | -- | 99.86% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -56.79% | -56.79% | 204.12% | 23.26% | 76.09% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 359.70% | 273.82% | 275.72% | 161.83% | 79.52% |